Johnson & Johnson
J&J accepts $4 bn bid from Carlyle for its ortho-clinical diagnostics business
01 April 2014
J&J to sell Ortho Clinical Diagnostics unit to Carlyle for $4.15 bn
17 January 2014
Danaher, Blackstone Group jointly bid for Johnson & Johnson's diagnostics unit
08 November 2013
Mis-selling of drugs to cost J&J $2.2 bn in US settlement
05 November 2013
PE firms in race for J&Jís Ortho Clinical Diagnostics unit
01 October 2013
J&J launches sale of Ortho Clinical Diagnostics unit
07 September 2013
J&J to buy Aragon Pharmaceuticals; deal potential $1 bn
17 June 2013
Johnson & Johnson recalling birth control pill Cilest
06 June 2013
Johnson & Johnson recalls childrenís Tylenol in South Korea
06 May 2013
Johnson & Johnsonís plant licence revoked on quality concerns
04 May 2013
J&J to pay $8.3 mn for hip-implant metal poisoning in first of 11,000 lawsuits
09 March 2013
Johnson & Johnson weighs sale of Women's Health division: report
28 January 2013
J & J to pay $181 million to settle Risperdal's illegal marketing claims
31 August 2012
Genmab in $1.1-bn onco drug licencing deal with Johnson & Johnson
30 August 2012
Janssen licences diabetes research from Evotec and Harvard University
11 July 2012
J&J gets final US nod for $19.7-bn Synthes acquisition
14 June 2012
Johnson & Johnson to set aside $600 mn for Risperdal lawsuits settlement
09 June 2012
Lawsuits spur J&J to stop sales of vaginal mesh implants
06 June 2012
Johnson & Johnsonís $21 billion bid for Synthes gets EU nod
19 April 2012
Forest Laboratories buys hypertension drug rights from J&J for $357 mn
02 April 2012
J&J offers EU concessions for $21.3 bn takeover of medical device firm Synthes
23 February 2012
Rejected in the US, J&J sells hip implant overseas
16 February 2012
European regulator launches antitrust probe against Novartis and J&J
24 October 2011
J&J unit wins lawsuit over antibiotic Levaquin drug side effects
15 October 2011
Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million
29 September 2011
Johnson & Johnson recalls anaemia drug Eprex in 17 countries
24 September 2011
J&J's Jansen to sell Ortho Dermatologics to Valeant for $345 mn
16 July 2011
EU regulator approves Eli Lillyís acquisition of J&Jís animal health unit
07 July 2011
J&J to buy J B Chemicalsí Russian OTC drugs for $260 million
24 May 2011
J&J to buy Swiss medical devices maker Synthes for $21.3 billion
27 April 2011
J&J may buy Synthes in $20-bn deal
16 April 2011
Eli Lilly to acquire Johnson & Johnsonís animal health unit
15 March 2011
Johnson & Johnson mulls fresh assault on Smith & Nephew: report
17 January 2011
J&Jís McNeil unit sells St Joseph's aspirin brand to Ilex Consumer Products
08 January 2011
J&J's McNeil unit recalls over 13 million packets of Rolaids
10 December 2010
Johnson & Johnson launches $2.32-bn bid for Dutch biotech firm Crucell NV
08 December 2010
J&J recalls Benadryl, Motrin
23 November 2010
J&J issues sixth Tylenol recall since November 2009
20 October 2010
Johnson & Johnson in talks to buy Crucell for $2.3 billion
17 September 2010
J&J unit DePuy issues global recall of 93,000 hip replacement systems
27 August 2010
J&J issues global recall for 1 Day Acuvue contact lenses
24 August 2010
J&J to buy stroke specialist Micrus Endovascular for $480 million
13 July 2010
Former chairman and CEO of Johnson & Johnson Richard B Sellars dies at 94
26 June 2010
Johnson & Johnson recalls 43 children's drugs
03 May 2010
Boston Scientific to pay J&J $1.73 billion in patent settlement
02 February 2010
J&J adds several popular brands to Tylenol recall lots
16 January 2010
US justice dept hauls J&J to court for paying kickbacks
16 January 2010
J&J to buy ENT device maker Acclarent for $785 million
17 December 2009
J&J to axe more than 7,000 jobs in restructuring
04 November 2009
Boston Scientific and Johnson & Johnson settle patent disputes
30 September 2009
J&J to invest $1.5 billion in Elanís Alzheimerís drugs
03 July 2009
J&J awarded $1.67 billion in patent suit against Abbott Laboratories
30 June 2009
J&J plans buyout of Cougar Biotech for $1 billion
23 May 2009
J&J, GSK, Novartis eye world's top dermatologist Stiefel
21 March 2009
China examining Johnson & Johnson baby products for possible toxins
19 March 2009
J&J buys breast implant maker Mentor Corp for $1.07 billion
01 December 2008
Johnson & Johnson acquires Omrix Biopharmaceuticas for $465 million
25 November 2008
US FDA probing deaths in German study involving J&J's anti-anemia drugs
03 October 2008
Tata's Advinus Therapeutics, J&J arm in drug development pact
01 October 2008
Johnson & Johnson (China) Investment Co., Ltd. Acquires Beijing Dabao Cosmetics Co., Ltd.
01 August 2008
Amgen to pay J&J's Ortho Biotech $200 million to settle suit
15 July 2008
Johnson & Johnson Nordic AB acquires Ňmic
23 June 2008
Johnson & Johnson patent lawsuit agains Boston Scientific's NIR stent dismissed in Canada
09 May 2008
P&G sues J&J for patent infringement on tooth-whitening strips
03 May 2008
J&J's acquisition of Pfizer Healthcare passes anti monopoly scrutiny
13 December 2006
J&J to acquire Pfizer Consumer Healthcare for $16.6 billion
26 June 2006
Boston Scientific beats J&J to acquire Guidant for $27 billion
25 January 2006
Johnson & Johnson launches the stent war
29 March 2005
FDA hauls up Johnson & Johnson on 'baby' branding
17 March 2005
Johnson & Johnson close to acquiring Alza
27 March 2001
Johnson & Johnson Ltd.
24 November 1999
J&J hives off adhesives unit to Premchand group
12 August 1999
 search domain-b
  go